Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service

Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
Sonia Prot-LabartheJean-François Bussières

Abstract

Hematopoietic stem cell transplant patients represent a population at high risk for drug-related problems. Our objective is to describe pharmacist interventions in a hematopoietic stem cell transplant pediatric unit. METHODS AND PATIENTS. The Hematopoietic Stem Cell Transplant Unit of the Centre Hospitalier Universitaire Sainte-Justine performs around 50 hematopoietic stem cell transplants per year. During a pharmaceutical care specialized residency program, a French pharmacist participated in certain clinical activities. Drug-related problems and clinical interventions were compiled over 31 nonconsecutive days using a tool developed by the Société Française de Pharmacie Clinique. Data concerning patients, drugs, intervention, documentation, approval (if needed), and estimated impact were compiled. During the 31-day period, 525 interventions were collected (16.9 +/- 3.7 per day), targeting 29 patients. The main drug-related problems were adverse drug reactions (N = 125, 23.8%), untreated indication (N = 92, 17.5%) and failure to receive drug (N = 89, 17.0%). The pharmacist's interventions concerned mainly dose adjustment (N = 174, 33.1%) and drug monitoring (N = 132, 25.1%). Among the 324 (61.7%) interventions requiring a physi...Continue Reading

References

Apr 1, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·B J Holcombe
Aug 26, 1998·Journal of the American Pharmaceutical Association : APhA·J A WaddellM K Wray
Oct 8, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·R W Holland, C M Nimmo
Jun 20, 2001·Pharmacy World & Science : PWS·H Boardman, R Fitzpatrick
Mar 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Helen T WuCourtney W Yuen
Aug 3, 2006·The Annals of Pharmacotherapy·Sachin ShahShane Greene
Sep 21, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Eva Rämme BrembergStaffan Eksborg
Oct 27, 2006·Pharmacy World & Science : PWS·Benoît AllenetOrnella Conort
Jan 30, 2007·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S Prot-LabartheF Brion
Feb 27, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jean-François BussièresDiane Larocque
Oct 19, 2007·Pharmacy World & Science : PWS·Sonia Prot-LabartheOlivier Bourdon
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·A Ghanizadeh

❮ Previous
Next ❯

Citations

Dec 25, 2012·International Journal of Clinical Pharmacy·Sonia Prot-LabartheOlivier Bourdon
Oct 4, 2012·The Annals of Pharmacotherapy·Kristin L ReppMichael A Borkon
Feb 23, 2018·International Journal of Clinical Pharmacy·Bharath R RavichandranBrian M Masters
Jun 13, 2018·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Maria Olívia Barboza-ZanettiLeonardo Régis Leira-Pereira
Oct 9, 2012·Journal of Pediatric Hematology/oncology·Sonia Prot-LabartheOlivier Bourdon
Dec 12, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Cynara S OliveiraRenata F de Araújo-Calumby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Annales de biologie clinique
Anne-Sophie BargnouxWorking group of the French Society of Clinical Chemistry and the French Society of Nephrology
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Académie Canadienne De Psychiatrie De L'enfant Et De L'adolescent
Don Quang TranYves Lajoie
International Journal of Pediatrics
Laetiscia LavoieSylvie Lafrenaye
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Erika VielXavier Pivot
© 2022 Meta ULC. All rights reserved